Mild processing defect of porcine ΔF508-CFTR suggests that ΔF508 pigs may not develop cystic fibrosis disease

Y Liu, Y Wang, Y Jiang, N Zhu, H Liang, L Xu… - Biochemical and …, 2008 - Elsevier
Y Liu, Y Wang, Y Jiang, N Zhu, H Liang, L Xu, X Feng, H Yang, T Ma
Biochemical and biophysical research communications, 2008Elsevier
Recent efforts have made significant progress in generating transgenic pigs with the ΔF508-
CFTR mutation to model the lung and pancreatic disease of human cystic fibrosis. However,
species differences in the processing and function of human, pig and mouse ΔF508-CFTR
reported recently raise concerns about the phenotypic consequence of the gene-targeted
pig model. The purpose of the present study was to characterize the ΔF508 mutant of
porcine CFTR to evaluate the severity of its processing defect. Biochemical and …
Recent efforts have made significant progress in generating transgenic pigs with the ΔF508-CFTR mutation to model the lung and pancreatic disease of human cystic fibrosis. However, species differences in the processing and function of human, pig and mouse ΔF508-CFTR reported recently raise concerns about the phenotypic consequence of the gene-targeted pig model. The purpose of the present study was to characterize the ΔF508 mutant of porcine CFTR to evaluate the severity of its processing defect. Biochemical and immunofluorescence analysis in transfected COS7 and FRT cells indicated that pig ΔF508-CFTR efficiently targets to the plasma membrane and is present mainly as the mature glycosylated protein. Functional characterization in stably transfected FRT cells by fluorometric and electrophysiological assays supported efficient plasma membrane targeting of pig ΔF508-CFTR. The mild cellular processing defect of pig ΔF508-CFTR suggests that its gene-targeted pig model may not develop the lung and pancreatic phenotypes seen in CF patients.
Elsevier